logo
Boston's St. Patrick's Day may be known for a boozy good time, but more are opting to forgo the buzz

Boston's St. Patrick's Day may be known for a boozy good time, but more are opting to forgo the buzz

Boston Globe17-03-2025

Yet while the holiday has become connected to heavy drinking over the centuries, a small but growing crowd has found ways to participate in the St. Patrick's Day parades, festivals and banquets without a buzz. They're doing so by turning to nonalcoholic beers, mocktails and solely sober spaces — even in the heart of Boston.
A holiday that's not just about booze
Advertisement
'St. Patrick's Day is a huge drinking holiday. It is promoted absolutely everywhere,' said Jackie Taylor who has been sober for 12 years.
But she's found lots of ways to celebrate the holiday — whether out on the town or at home — without risking a situation where 'you might not make it out of there sober.'
Nonalcoholic drinks are popular on St. Patrick's Day weekend during The Burren's four days of Irish music shows, which can last 10 hours each. McCarthy said he's a Guinness drinker but sticks to the nonalcoholic brew when playing the fiddle.
'I top it up with the real creamy alcohol head,' he said. 'You're only getting a small bit of the alcohol, but you get the real cream. But you're also getting the taste of the real Guinness without the alcohol. It kind of beats all.'
Michelle Flynn, manager at the Brendan Behan Irish pub in Boston's Jamacia Plain, said most bars now serve nonalcoholic beers — a significant shift from decades ago.
'The neighborhood, society, everything has changed, has shifted a 1,000% — especially in the youth,' she said.
Advertisement
Young people don't drink as much anymore
It's not just bar owners noticing an uptick in a demand for nonalcoholic options. Young adults are drinking less than they were in decades past, according to polling by Gallup, which reported in 2023 that adults under 35 were less likely to say they use alcohol at least occasionally than they were in the early 2000s.
Gallup also saw a decline in the share of young adults who drink regularly or say they sometimes drink 'more than they think they should' over the same time period.
Michael Scelfo, chef and owner of four Boston area cocktail bars, said his businesses have served mocktails since he opened Cambridge-based Alden & Harlow 11 years ago. But after the pandemic, demand significantly increased.
'It's really kind of an expected and formidable part of the menu now,' he said, with bartenders putting just as much care into a mocktail's execution.
Reclaiming St. Patrick's Day for Irish heritage
For nearly 15 years, William Spencer Reilly has been throwing a " Sober St. Patrick's Day " in New York City — which kicks off after the parade with Irish bands, dancers and food — and may soon expand the mission to Boston.
The sober event's founder and chairman has always had his eye on Boston 'for all the obvious reasons.'
According to Reilly, it's about refocusing the typically-booze forward festivities on celebrating Irish heritage and honoring St. Patrick, the priest born in the late fourth century who was enslaved in Ireland and later returned to promote the spread of Christianity. It's also a chance to break hurtful stereotypes of Irish people.
When he first proposed the idea of a sober event on such a booze-heavy day, he was met with incredulity and doubt over public interest. Now he's in talks with Boston's local leaders and believes there's finally enough interest and support to branch out next year.
Advertisement
People generally seem more interested in being healthier, said Scelfo. That includes how they choose to spend their holidays.
'The perils and pitfalls of alcohol are well-documented when not used responsibly,' he said. 'We've got an intelligent young generation that's focused on health and wellness. And I think that that's a great thing.'
Krusei reported from Nashville, Tennessee, and Willingham reported from Charleston, West Virginia. Amelia Thomson DeVeaux in Washington D.C. contributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Todd Vande Hei Breaks Down the 'Mismatch Theory' in "Health is a Skill" Podcast Episode on Health Optimization
Todd Vande Hei Breaks Down the 'Mismatch Theory' in "Health is a Skill" Podcast Episode on Health Optimization

Yahoo

timean hour ago

  • Yahoo

Todd Vande Hei Breaks Down the 'Mismatch Theory' in "Health is a Skill" Podcast Episode on Health Optimization

Stark CEO explores evolutionary biology, EMFs, and modern wellness strategies in an episode aimed at bridging the gap between body design and today's environment Todd Vande Hei delivers a thought-provoking solo episode on evolutionary health, stress, and modern resilience. Beverly Hills, California, June 17, 2025 (GLOBE NEWSWIRE) -- In a powerful solo episode of Health is a Skill, Stark CEO Todd Vande Hei explores the concept of the 'mismatch theory,' offering a comprehensive look at how modern comforts may be undermining human health. Drawing from evolutionary biology and his own extensive health journey, Vande Hei shares a deeply personal and data-backed perspective on optimizing well-being in a world that's increasingly out of sync with human physiology. 'Softness is the same as misery over the long haul,' Vande Hei declares, challenging listeners to reevaluate their approach to convenience and comfort. He connects the dots between electromagnetic fields (EMFs), reduced mitochondrial function, chronic fatigue, and the alarming decline in hormonal health—especially among young men. The episode delves into scientific literature, including a 2021 meta-review linking EMF exposure to oxidative stress and a 2016 study that showed significant decreases in mitochondrial function due to electromagnetic exposure. 'We're stone-agers living in the space age,' Vande Hei notes, referencing anthropologist Daniel Lieberman's work on the biological mismatch between human evolution and industrialized environments. In his signature blend of science and storytelling, Vande Hei breaks down mitochondrial health, ATP production, apoptosis, and their critical roles in longevity and performance. He also covers practical strategies such as infrared sauna use, cold exposure, circadian rhythm alignment, and clean air and water practices. Listeners are urged to incorporate daily discomforts—like walking more, fasting, and avoiding ultra-processed foods—into their routines to build metabolic and psychological resilience. 'You can't live like a caveman in the 21st century,' Vande Hei says, 'but you can steal the best parts of that lifestyle and blend them with modern tools.' This episode serves as a blueprint for anyone navigating the toxicities of modern life while seeking optimal health. Tune in via YouTube, Spotify, or Apple Podcasts. About Health Is a Skill Health is a Skill is a Los Angeles-based podcast hosted by Todd Vande Hei, CEO of Stark. Each episode combines scientific insight, real-world strategies, and expert conversations to help listeners bridge the gap between their biology and the modern world—empowering them to live longer, healthier lives. Media Communications: Inquiries: adamtorres@ Attachment Todd Vande Hei delivers a thought-provoking solo episode on evolutionary health, stress, and modern in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Dr. Andrew Gomes Launches New Scholarship to Support U.S. Veteran Undergraduate Students
Dr. Andrew Gomes Launches New Scholarship to Support U.S. Veteran Undergraduate Students

Yahoo

time2 hours ago

  • Yahoo

Dr. Andrew Gomes Launches New Scholarship to Support U.S. Veteran Undergraduate Students

Dr. Andrew Gomes HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- In a powerful show of support for America's veterans, leading Diagnostic Radiologist Dr. Andrew Gomes has announced the creation of the Dr. Andrew Gomes Scholarship for Veterans, a new opportunity aimed at empowering those who have served in the military and are now pursuing undergraduate degrees. The scholarship, which is awarded through an essay-based application process, is now accepting submissions through March 15, 2026. The winning recipient will be announced on April 15, 2026. A recognized expert in advanced neuroimaging of traumatic brain injury (TBI), Dr. Gomes has spent more than a decade working at the intersection of healthcare and patient advocacy. His deep respect for veterans—especially those impacted by service-related injuries—inspired him to create this scholarship as a meaningful way to give back. 'Veterans possess a remarkable combination of strength, discipline, and resilience,' said Dr. Gomes. 'This scholarship is my way of acknowledging their sacrifices and helping support the next stage of their journey through education.' Who Is Eligible The scholarship is open to veterans of the U.S. Armed Forces who are currently enrolled as undergraduate students at accredited colleges or universities within the United States. Students from all branches of the military, including active-duty veterans, Reserve, and National Guard members, are encouraged to apply. Application Requirements In order to apply, students must submit an original essay and provide documentation of both their military service and their current enrollment in an undergraduate program. Essay Topic: "In what ways has your military service shaped who you are today, and how do you plan to lead or make a difference in your post-service life through education?" Essays should be between 500–750 words and will be assessed based on depth of insight, clarity of expression, and connection to the scholarship's mission of leadership, purpose, and growth. How to Apply To submit an application, students should email the following items to apply@ A 500–750 word essay (in PDF or Word format) Proof of veteran status (e.g., DD-214 or valid military ID) Verification of undergraduate enrollment (e.g., current transcript or enrollment confirmation) Full name and contact information (email and phone number) Deadline to apply: March 15, 2026Winner announced: April 15, 2026 About Dr. Andrew Gomes Dr. Andrew Gomes is a Texas-based Radiologist specializing in Diagnostic and Non-Vascular Interventional Radiology, with additional experience in Diffusion Tensor Imaging (DTI) for traumatic brain injury. Over his 15-year career, he has built a reputation for innovation, precision, and integrity. He is passionate about bridging science and advocacy, helping TBI patients gain proper diagnosis and legal recognition. Through this scholarship, Dr. Gomes continues his commitment to helping those who have served by investing in their future through education. To learn more about the scholarship, eligibility, and application details, please visit Contact Info: Spokesperson: Dr. Andrew Gomes Organization: Dr. Andrew Gomes Scholarship Website: Email: apply@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs
Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

Miami Herald

time2 hours ago

  • Miami Herald

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

June 17 (UPI) --Eli Lilly and Company said Tuesday it will buy out Boston-based Verve Therapeutics Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs. Indianapolis-based Eli Lilly announced its definitive agreement to acquire Verge, a gene-editing startup, for up to $1.3 billion at $10.50 a share -- a premium of 67.5% at last closing -- with the goal to boost Verve's budding pipeline of medicine designed to target and treat a wide-range of cardiovascular-related health issues. "Lilly is eager to welcome our Verve colleagues to Lilly and continue the development of these promising potential new medicines aimed at improving outcomes for patients with cardiovascular disease and addressing the significant unmet medical need in this space," said Ruth Gimeno, Lilly's group VP for diabetes and metabolic research and development. Under the agreement terms, the transaction will not be subject to any financing conditions and will include a nearly $1 billion upfront payout plus a further $300 million based on certain clinical milestones. The deal is expected to close by this year's third quarter subject to conditions. Verve's medical treatment program, according to a Gimeno, could "shift the treatment paradigm for cardiovascular disease from chronic care to one-and-done treatment." Meanwhile, stock shares in Verve jumped 76% to over $11 in premarket trading Tuesday morning while Lilly stock value fell 1%. A years-long study from 2010-2022 released in November revealed how the number of dead via cardiovascular disease had surged among adults ages 25 to 64 living in rural areas. Verve uses a next gen type of gene editing which erases and rewrites a specific gene letter. Lilly's Gimeno says the Verve-102 program, which is currently in its Phase 1b clinal trial study and fast-tracked for FDA approval, "has the potential" to be the first "in vivo" gene editing therapy deployed to treat a broad population of patients seeking treatment for cardiac issues. 102 may be utilized for patients seeking treatment for heterozygous familial hypercholesterolemia (HeFH), which is a subset of ASCVD affecting 1 in 250 people. On Tuesday, Verve's chief noted how in just seven years that the Verve team had progressed three in vivo gene editing products with two currently in clinics. "Verve was founded with one mission in mind: transform the treatment of cardiovascular disease from chronic care to a one-dose future," said Verve Therapeutics co-founder and CEO Dr. Sekar Kathiresan. Copyright 2025 UPI News Corporation. All Rights Reserved.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store